Analyst Price Targets — INSP
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 16, 2026 2:05 pm | — | Truist Financial | $54.00 | $52.28 | TheFly | Inspire Medical price target raised to $54 from $50 at Truist |
| June 23, 2026 10:03 am | Daniel Markowitz | Evercore ISI | $40.00 | $41.35 | TheFly | Inspire Medical downgraded to In Line from Outperform at Evercore ISI |
| May 22, 2026 10:05 am | — | Summit Redstone Partners | $39.00 | $44.74 | StreetInsider | BofA Securities Downgrades Inspire Medical Systems (INSP) to Underperform |
| May 5, 2026 1:44 pm | Richard Newitter | Truist Financial | $50.00 | $45.95 | TheFly | Inspire Medical price target lowered to $50 from $64 at Truist |
| May 5, 2026 12:11 pm | — | RBC Capital | $45.00 | $44.98 | TheFly | Inspire Medical price target lowered to $45 from $56 at RBC Capital |
| May 5, 2026 12:10 pm | — | Evercore ISI | $55.00 | $45.56 | TheFly | Inspire Medical price target lowered to $55 from $62 at Evercore ISI |
| May 5, 2026 10:27 am | David Rescott | Robert W. Baird | $50.00 | $54.84 | TheFly | Inspire Medical price target lowered to $50 from $63 at Baird |
| May 5, 2026 8:53 am | Adam Maeder | Piper Sandler | $55.00 | $54.84 | TheFly | Inspire Medical downgraded to Neutral from Overweight at Piper Sandler |
| April 15, 2026 12:29 pm | — | Truist Financial | $64.00 | $57.59 | TheFly | Inspire Medical price target lowered to $64 from $70 at Truist |
| April 14, 2026 11:22 am | Shagun Singh | RBC Capital | $56.00 | $54.92 | TheFly | Inspire Medical price target lowered to $56 from $68 at RBC Capital |
Latest News for INSP
Inspire Medical's Inspire V rollout, broader approvals and clinical evidence support growth despite coding and reimbursement pressures.
Inspire Medical Investigation Continued: Kahn Swick and Foti, LLC Continues to Investigate the Officers and Directors of Inspire Medical Systems,
NEW YORK and NEW ORLEANS, July 10, 2026 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq.
MINNEAPOLIS, July 06, 2026 (GLOBE NEWSWIRE) -- This press release corrects the earnings release date included in the earlier version issued on July 6, 2026. No other information has changed.
MINNEAPOLIS, July 06, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the second quarter 2026 after the close of trading on Monday, August 3. Inspire's management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for INSP.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.